Annual CFO
-$50.90 M
+$2.60 M+4.85%
31 December 2023
Summary:
Akoya Biosciences annual cash flow from operations is currently -$50.90 million, with the most recent change of +$2.60 million (+4.85%) on 31 December 2023. During the last 3 years, it has fallen by -$14.83 million (-41.12%). AKYA annual CFO is now -643.81% below its all-time high of -$6.84 million, reached on 31 December 2020.AKYA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$9.26 M
+$1.78 M+16.17%
30 September 2024
Summary:
Akoya Biosciences quarterly cash flow from operations is currently -$9.26 million, with the most recent change of +$1.78 million (+16.17%) on 30 September 2024. Over the past year, it has dropped by -$3.67 million (-65.76%). AKYA quarterly CFO is now -867.19% below its all-time high of -$957.00 thousand, reached on 31 March 2020.AKYA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$46.70 M
+$4.50 M+8.78%
30 September 2024
Summary:
Akoya Biosciences TTM cash flow from operations is currently -$46.70 million, with the most recent change of +$4.50 million (+8.78%) on 30 September 2024. Over the past year, it has increased by +$4.19 million (+8.24%). AKYA TTM CFO is now -4780.36% below its all-time high of -$957.00 thousand, reached on 31 March 2020.AKYA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKYA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -65.8% | +8.2% |
| 3 y3 years | -41.1% | -58.1% | -29.5% |
| 5 y5 years | -269.5% | - | - |
AKYA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.1% | +4.8% | -65.8% | +55.5% | -29.5% | +15.6% |
| 5 y | 5 years | -643.8% | +4.8% | -867.2% | +55.5% | -4780.4% | +15.6% |
| alltime | all time | -643.8% | +4.8% | -867.2% | +55.5% | -4780.4% | +15.6% |
Akoya Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.26 M(-16.2%) | -$46.70 M(-8.8%) |
| June 2024 | - | -$11.04 M(-47.0%) | -$51.20 M(-1.5%) |
| Mar 2024 | - | -$20.82 M(+272.9%) | -$51.97 M(+2.1%) |
| Dec 2023 | -$50.90 M(-4.9%) | -$5.58 M(-59.4%) | -$50.90 M(-8.0%) |
| Sept 2023 | - | -$13.75 M(+16.5%) | -$55.32 M(+2.9%) |
| June 2023 | - | -$11.80 M(-40.3%) | -$53.74 M(-2.9%) |
| Mar 2023 | - | -$19.76 M(+97.4%) | -$55.32 M(+3.4%) |
| Dec 2022 | -$53.50 M | -$10.01 M(-17.8%) | -$53.50 M(+8.4%) |
| Sept 2022 | - | -$12.17 M(-9.1%) | -$49.34 M(-2.4%) |
| June 2022 | - | -$13.39 M(-25.4%) | -$50.57 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$17.93 M(+206.3%) | -$49.60 M(+37.5%) |
| Dec 2021 | -$36.07 M(+427.1%) | -$5.85 M(-56.3%) | -$36.07 M(+11.5%) |
| Sept 2021 | - | -$13.39 M(+7.9%) | -$32.36 M(+56.3%) |
| June 2021 | - | -$12.41 M(+181.9%) | -$20.71 M(+101.2%) |
| Mar 2021 | - | -$4.40 M(+105.1%) | -$10.29 M(+50.4%) |
| Dec 2020 | -$6.84 M(-50.3%) | -$2.15 M(+23.4%) | -$6.84 M(+45.7%) |
| Sept 2020 | - | -$1.74 M(-13.0%) | -$4.70 M(+58.9%) |
| June 2020 | - | -$2.00 M(+108.9%) | -$2.96 M(+208.9%) |
| Mar 2020 | - | -$957.00 K | -$957.00 K |
| Dec 2019 | -$13.78 M | - | - |
FAQ
- What is Akoya Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Akoya Biosciences?
- What is Akoya Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Akoya Biosciences?
- What is Akoya Biosciences quarterly CFO year-on-year change?
- What is Akoya Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Akoya Biosciences?
- What is Akoya Biosciences TTM CFO year-on-year change?
What is Akoya Biosciences annual cash flow from operations?
The current annual CFO of AKYA is -$50.90 M
What is the all time high annual CFO for Akoya Biosciences?
Akoya Biosciences all-time high annual cash flow from operations is -$6.84 M
What is Akoya Biosciences quarterly cash flow from operations?
The current quarterly CFO of AKYA is -$9.26 M
What is the all time high quarterly CFO for Akoya Biosciences?
Akoya Biosciences all-time high quarterly cash flow from operations is -$957.00 K
What is Akoya Biosciences quarterly CFO year-on-year change?
Over the past year, AKYA quarterly cash flow from operations has changed by -$3.67 M (-65.76%)
What is Akoya Biosciences TTM cash flow from operations?
The current TTM CFO of AKYA is -$46.70 M
What is the all time high TTM CFO for Akoya Biosciences?
Akoya Biosciences all-time high TTM cash flow from operations is -$957.00 K
What is Akoya Biosciences TTM CFO year-on-year change?
Over the past year, AKYA TTM cash flow from operations has changed by +$4.19 M (+8.24%)